Article ; Online: Agonists or positive allosteric modulators of α7 nicotinic acetylcholine receptor prevent interaction of SARS-Cov-2 receptor-binding domain with astrocytoma cells.
Biochemical and biophysical research communications
2024 Volume 709, Page(s) 149825
Abstract: SARS-Cov-2, the virus causing COVID-19, penetrates host target cells via the receptor of angiotensin-converting enzyme 2 (ACE2). Disrupting the virus interaction with ACE2 affords a plausible mechanism for prevention of cell penetration and inhibiting ... ...
Abstract | SARS-Cov-2, the virus causing COVID-19, penetrates host target cells via the receptor of angiotensin-converting enzyme 2 (ACE2). Disrupting the virus interaction with ACE2 affords a plausible mechanism for prevention of cell penetration and inhibiting dissemination of the virus. Our studies demonstrate that ACE2 interaction with the receptor binding domain of SARS-Cov-2 spike protein (RBD) can be impaired by modulating the α7 nicotinic acetylcholine receptor (α7 nAChR) contiguous with ACE2. U373 cells of human astrocytoma origin were shown to bind both ACE2-specific antibody and recombinant RBD in Cell-ELISA. ACE2 was found to interact with α7 nAChR in U373 cell lysates studied by Sandwich ELISA. Our studies demonstrate that inhibition of RBD binding to ACE2-expressing U373 cells were defined with α7 nAChR agonists choline and PNU282987, but not a competitive antagonist methyllicaconitine (MLA). Additionally, the type 2 positive allosteric modulator (PAM2) PNU120596 and hydroxyurea (HU) also inhibited the binding. Our studies demonstrate that activation of α7 AChRs has efficacy in inhibiting the SARS-Cov-2 interaction with the ACE2 receptor and in such a way can prevent virus target cell penetration. These studies also help to clarify the consistent efficacy and positive outcomes for utilizing HU in treating COVID-19. |
---|---|
MeSH term(s) | Humans ; alpha7 Nicotinic Acetylcholine Receptor/metabolism ; Angiotensin-Converting Enzyme 2/metabolism ; COVID-19 ; Protein Binding ; Receptors, Nicotinic/metabolism ; SARS-CoV-2/metabolism ; Spike Glycoprotein, Coronavirus/chemistry |
Chemical Substances | alpha7 Nicotinic Acetylcholine Receptor ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23) ; Receptors, Nicotinic ; Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2 |
Language | English |
Publishing date | 2024-03-25 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 205723-2 |
ISSN | 1090-2104 ; 0006-291X ; 0006-291X |
ISSN (online) | 1090-2104 ; 0006-291X |
ISSN | 0006-291X |
DOI | 10.1016/j.bbrc.2024.149825 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 116: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.